Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005678
Filing Date
2025-04-28
Accepted
2025-04-28 16:05:24
Documents
20
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A fbio-20250617xdef14a.htm   iXBRL DEF 14A 1049274
2 GRAPHIC fbio-20250617xdef14a_a001.jpg GRAPHIC 6520
3 GRAPHIC fbio-20250617xdef14a_a008.jpg GRAPHIC 45944
4 GRAPHIC fbio-20250617xdef14a_a009.jpg GRAPHIC 40434
5 GRAPHIC fbio-20250617xdef14a_bg001.jpg GRAPHIC 128639
6 GRAPHIC fbio-20250617xdef14a_bg002.jpg GRAPHIC 150537
  Complete submission text file 0001558370-25-005678.txt   2603733

Data Files

Seq Description Document Type Size
7 EX-101.SCH fbio-20250617.xsd EX-101.SCH 3813
8 EX-101.LAB fbio-20250617_lab.xml EX-101.LAB 3686
9 EX-101.PRE fbio-20250617_pre.xml EX-101.PRE 3940
22 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20250617xdef14a_htm.xml XML 146410
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35366 | Film No.: 25880250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)